June 11, 2008: Cellectricon
Cellectricon and AstraZeneca – partners in new high throughput ion channel drug discovery technology

June 6, 2008: WILEX
WILEX and IBA enter into worldwide marketing, distribution and sales agreement on REDECTANE®

May 27, 2008: Sidec
The Protein Tomographyª Award Now Published on Sidec’s Homepage

May 20, 2008: NsGene
Capital Infusion and New Chairman

May 19, 2008: WILEX
Patient recruitment started in Phase III registration trial with CA9-SCAN

May 6, 2008: Sidec
Sidec AB expands into new offices

May 1, 2008: Sidec
Sidec announces the first Protein Tomographyª Award at Sidec’s Executive Forum at PEGS

April 29, 2008: Cellectricon
Jonas Ohlsson appointed CEO/President of Cellectricon

April 25, 2008: Gyros
Breakthrough sales to German CMO market and continued repeat purchases confirms the importance of Gyrolab for therapeutic antibody development

April 25, 2008: Independent Pharmaceutica
Swedish vaccine against smoking enters clinical trial phase II

April 22, 2008: Sidec
Protein Tomographyª reveals molecular mode of action of humax - EGFr

April 10, 2008: WILEX
WILEX reports successful first quarter 2008

April 7, 2008: NsGene
Danish biotech company’s restorative Alzheimer’s product has successfully been implanted in patients

March 27, 2008: Cellectricon
Cellectricon launches worlds first system for high throughput RNAi screening

February 21, 2008: Cellectricon
Share issue gives Cellectricon SEK 89 million to continue its rapid market expansion

February 21, 2008: Sidec
Sidec is Granted 4 Million SEK for Vizualisation Project

February 20, 2008: Wilex
WILEX reports a successful financial year 2007– positive outlook for 2008

February 11, 2008: Wilex
FDA issues Special Protocol Assessment (SPA) for pivotal Phase III trial with CA9-SCAN

February 7, 2008: Genizon BioSciences
Genizon BioSciences Collaborating with London Genetics to Enhance Gene Discovery Findings in Schizophrenia

January 31, 2008: CanAg
CanAg CA242 EIA - Updated folder

January 28, 2008: Wilex
WILEX receives US FDA approval (IND) for clinical Phase II trial with its uPA inhibitor WX-671 in metastatic breast cancer

January 25, 2008: Wilex
Phase I study with uPA inhibitor WX-UK1 successfully completed

January 21, 2008: Phasein
EMMA/Capnocheck Airway Adapter Infant receives 510k FDA clearance

January 15, 2008: Gyros AB
New CEO at Gyros AB

January 7, 2008: Genizon BioSciences
Genizon BioSciences Secures $31 Million In Additional Financing

January 3, 2008: CanAg
CanAg SCC EIA - Updated folder